Exo vs Noom
Side-by-side comparison of AI visibility scores, market position, and capabilities
Exo is a Redwood City medtech company developing handheld ultrasound devices using proprietary silicon-based PMUT technology; raised $220M+ in funding including a $100M Series C in 2022;
About
Exo is a medical technology company founded in 2015 and headquartered in Redwood City, California, focused on making high-performance ultrasound imaging accessible at the point of care. The company's hardware innovation centers on a proprietary silicon-based ultrasound transducer technology using Piezoelectric Micromachined Ultrasonic Transducers (PMUTs) — a semiconductor manufacturing approach to building ultrasound transducers rather than the traditional piezoelectric ceramic crystal approach used in conventional ultrasound probes. The PMUT-on-chip architecture enables Exo to produce ultrasound transducers that are significantly smaller, thinner, and lower-cost to manufacture at scale than conventional transducer technology, while potentially enabling future integration with computing electronics on the same chip.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
About
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.